{"transactions":[{"id":2217039,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:41:11.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the merger agreement between issuer, GSK and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option fully vested on June 8, 2022."}],"balance_after":0,"derivative":{"exercise_price":18.11,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-22-040266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919122040266/doc4.xml","form_type":"4"}},{"id":2217038,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:41:11.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":16686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the merger agreement between issuer, GSK and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option fully vested on June 9, 2021."}],"balance_after":0,"derivative":{"exercise_price":13.98,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":16686},"source":{"system":"sec-edgar","filing":"0001209191-22-040266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919122040266/doc4.xml","form_type":"4"}},{"id":2217037,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:41:11.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the merger agreement between issuer, GSK and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option fully vested on June 11, 2020."}],"balance_after":0,"derivative":{"exercise_price":26.4,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001209191-22-040266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919122040266/doc4.xml","form_type":"4"}},{"id":2217036,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:41:11.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option fully vested on June 12, 2019."}],"balance_after":0,"derivative":{"exercise_price":130.8,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001209191-22-040266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919122040266/doc4.xml","form_type":"4"}},{"id":2217035,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:41:11.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the merger agreement between issuer, GSK and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option fully vested on June 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":45.2,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001209191-22-040266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919122040266/doc4.xml","form_type":"4"}},{"id":2217034,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:41:11.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option fully vested on June 16, 2017."}],"balance_after":0,"derivative":{"exercise_price":82.4,"expiration_date":"2026-06-16","underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001209191-22-040266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919122040266/doc4.xml","form_type":"4"}},{"id":2217033,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:41:11.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option fully vested on June 18, 2016."}],"balance_after":0,"derivative":{"exercise_price":268.2,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":671},"source":{"system":"sec-edgar","filing":"0001209191-22-040266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919122040266/doc4.xml","form_type":"4"}},{"id":2675437,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2021-06-09T10:38:25.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option fully vests and becomes exercisable on June 8, 2022, subject to the Reporting Person's provision of service to the Issuer as of the vesting date."}],"balance_after":6000,"derivative":{"exercise_price":18.11,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-21-039092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919121039092/doc4.xml","form_type":"4"}},{"id":3114562,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-10T19:01:52.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":16686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.333% of the total shares monthly, beginning on July 9, 2020, with 100% of the total shares vested and exercisable on June 9, 2021, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":16686,"derivative":{"exercise_price":13.98,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":16686},"source":{"system":"sec-edgar","filing":"0001209191-20-035690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919120035690/doc4.xml","form_type":"4"}},{"id":3492551,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-12T17:55:24.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.333% of the total shares monthly, beginning on July 11, 2019, with 100% of the total shares vested and exercisable on June 11, 2020, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.66,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-036491","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919119036491/doc4.xml","form_type":"4"}},{"id":3893651,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-14T17:10:04.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.333% of the total shares monthly, beginning on July 12, 2018, with 100% of the total shares vested and exercisable on June 12, 2019, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":3.27,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-037790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919118037790/doc4.xml","form_type":"4"}},{"id":3940815,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-09T22:17:37.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable at a rate of 1/12th of the total number of shares underlying the options on the one-month anniversary of May 7, 2018 (the \"Vesting Commencement Date\") and 1/12th of the total number of shares underlying the options each monthly anniversary of the Vesting Commencement Date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the one-year anniversary of the Vesting Commencement Date."}],"balance_after":15000,"derivative":{"exercise_price":13.1,"expiration_date":"2028-05-06","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-028983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919118028983/doc4.xml","form_type":"4"}},{"id":4282103,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-14T17:31:45.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.333% of the total shares monthly, beginning on July 13, 2017, with 100% of the total shares vested and exercisable on June 13, 2018, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.13,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-039878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297500/000120919117039878/doc4.xml","form_type":"4"}},{"id":4326522,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":125701,"kind":"person","name":"Pelzer Robert","position":1,"cik":"0001297500","reported_name":"Pelzer Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-10T22:36:40.000Z","date":"2017-05-08","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable at a rate of 1/12th of the total number of shares underlying the options on the one-month anniversary of May 8, 2017 (the \"Vesting Commencement Date\") and 1/12th of the total number of shares underlying the options each monthly anniversary of the Vesting Commencement Date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the one-year anniversary of the Vesting Commencement Date."}],"balance_after":9000,"derivative":{"exercise_price":13.74,"expiration_date":"2027-05-07","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-17-031399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117031399/doc4.xml","form_type":"4"}}]}